RNA Signature as Potential Diagnostic Marker for Differentiation of Pancreatic Cysts: A Pilot Study. [PDF]
Freylikhman O +7 more
europepmc +1 more source
Updates in diagnosis and management of pancreatic cysts. [PDF]
Lee LS.
europepmc +1 more source
This review systematically summarizes the central role of cysteine peptidases in modulating antigen‐presenting cell (APC) function and antitumor immune responses, highlighting their critical significance in overcoming tumor immune evasion. Current research has established that cysteine peptidase subtypes, including cathepsins B, S, L, and X, exert ...
Yimao Wu +7 more
wiley +1 more source
Trifecta of Cysts: Unraveling the Diagnosis in a Patient With Renal, Hepatic, and Pancreatic Cysts. [PDF]
Washington AN +3 more
europepmc +1 more source
Autoimmune Pancreatitis with Massive Ascites and Multiple Pancreatic Cysts Successfully Treated with Prednisolone. [PDF]
Kido K +14 more
europepmc +1 more source
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
Perceived factors influencing patient acceptance of reduced surveillance of low-risk pancreatic cysts - A Dutch focus group study. [PDF]
Sprij MLJA +6 more
europepmc +1 more source
State-of-the-Art Update of Pancreatic Cysts. [PDF]
Canakis A, Lee LS.
europepmc +1 more source
Multi‐omics–driven precision medicine
Multi‐omics‐driven precision medicine (MODPM) provides a multiscale, continuously learnable framework that integrates genomics, epigenomics, transcriptomics, proteomics, metabolomics, microbiome profiles, and clinical data. Powered by artificial intelligence and foundation models, MODPM enables cross‐modal representation learning, contextual modeling ...
Huibo Li +20 more
wiley +1 more source
Clinical Benefits of KRAS/GNAS Gene Mutation Analysis in Addition to Morphology and Conventional Cyst Fluid Testing in Differentiating Pancreatic Cysts. [PDF]
Gyimesi G +11 more
europepmc +1 more source

